These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 20733047)

  • 1. Phenotypic and biochemical comparison of the carbapenem-hydrolyzing activities of five plasmid-borne AmpC β-lactamases.
    Mammeri H; Guillon H; Eb F; Nordmann P
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4556-60. PubMed ID: 20733047
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contribution of asparagine 346 residue to the carbapenemase activity of CMY-2 β-lactamase.
    Dahyot S; Broutin I; de Champs C; Guillon H; Mammeri H
    FEMS Microbiol Lett; 2013 Aug; 345(2):147-53. PubMed ID: 23763375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.
    Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y
    J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Investigation of plasmid mediated AmpC beta-lactamases among Escherichia coli and Klebsiella pneumoniae isolated from blood cultures].
    Sarı AN; Biçmen M; Gülay Z
    Mikrobiyol Bul; 2013 Oct; 47(4):582-91. PubMed ID: 24237427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of extended-spectrum AmpC (ESAC) beta-lactamases to carbapenem resistance in Escherichia coli.
    Mammeri H; Nordmann P; Berkani A; Eb F
    FEMS Microbiol Lett; 2008 May; 282(2):238-40. PubMed ID: 18371063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis spectrum extension of CMY-2-like β-lactamases resulting from structural alteration in the Y-X-N loop.
    Dahyot S; Mammeri H
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1151-6. PubMed ID: 22232281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acquisition of Carbapenem Resistance by Plasmid-Encoded-AmpC-Expressing Escherichia coli.
    van Boxtel R; Wattel AA; Arenas J; Goessens WH; Tommassen J
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In Vivo Evolution of CMY-2 to CMY-33 β-Lactamase in Escherichia coli Sequence Type 131: Characterization of an Acquired Extended-Spectrum AmpC Conferring Resistance to Cefepime.
    Pires J; Taracila M; Bethel CR; Doi Y; Kasraian S; Tinguely R; Sendi P; Bonomo RA; Endimiani A
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7483-8. PubMed ID: 26392491
    [TBL] [Abstract][Full Text] [Related]  

  • 9. False-Positive Carbapenem-Hydrolyzing Confirmatory Tests Due to ACT-28, a Chromosomally Encoded AmpC with Weak Carbapenemase Activity from Enterobacter kobei.
    Jousset AB; Oueslati S; Bernabeu S; Takissian J; Creton E; Vogel A; Sauvadet A; Cotellon G; Gauthier L; Bonnin RA; Dortet L; Naas T
    Antimicrob Agents Chemother; 2019 May; 63(5):. PubMed ID: 30783006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasmid-Encoded AmpC and Extended-Spectrum Beta-Lactamases in Multidrug-Resistant
    Cardoso O; Osório S; Ramos F; Donato MM
    Microb Drug Resist; 2021 Dec; 27(12):1742-1749. PubMed ID: 34191606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
    Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
    Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.
    Goessens WH; van der Bij AK; van Boxtel R; Pitout JD; van Ulsen P; Melles DC; Tommassen J
    Antimicrob Agents Chemother; 2013 Aug; 57(8):3941-9. PubMed ID: 23733461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imipenem resistance in Klebsiella pneumoniae is associated to the combination of plasmid-mediated CMY-4 AmpC β-lactamase and loss of an outer membrane protein.
    Dahmen S; Mansour W; Charfi K; Boujaafar N; Arlet G; Bouallègue O
    Microb Drug Resist; 2012 Oct; 18(5):479-83. PubMed ID: 22690752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. OXA-427, a new plasmid-borne carbapenem-hydrolysing class D β-lactamase in Enterobacteriaceae.
    Bogaerts P; Naas T; Saegeman V; Bonnin RA; Schuermans A; Evrard S; Bouchahrouf W; Jove T; Tande D; de Bolle X; Huang TD; Dortet L; Glupczynski Y
    J Antimicrob Chemother; 2017 Sep; 72(9):2469-2477. PubMed ID: 28859446
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of multidrug resistant ESBL- and plasmid mediated AmpC-producing clinical isolates of Escherichia coli at Maputo Central Hospital, Mozambique.
    Estaleva CEL; Zimba TF; Sekyere JO; Govinden U; Chenia HY; Simonsen GS; Haldorsen B; Essack SY; Sundsfjord A
    BMC Infect Dis; 2021 Jan; 21(1):16. PubMed ID: 33407206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild Birds, Frequent Carriers of Extended-Spectrum β-Lactamase (ESBL) Producing Escherichia coli of CTX-M and SHV-12 Types.
    Alcalá L; Alonso CA; Simón C; González-Esteban C; Orós J; Rezusta A; Ortega C; Torres C
    Microb Ecol; 2016 Nov; 72(4):861-869. PubMed ID: 26687342
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of conjugative plasmid-mediated AmpC beta-lactamases in the United States.
    Alvarez M; Tran JH; Chow N; Jacoby GA
    Antimicrob Agents Chemother; 2004 Feb; 48(2):533-7. PubMed ID: 14742206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Updated molecular epidemiology of carbapenem-non-susceptible Escherichia coli in Taiwan: first identification of KPC-2 or NDM-1-producing E. coli in Taiwan.
    Ma L; Siu LK; Lin JC; Wu TL; Fung CP; Wang JT; Lu PL; Chuang YC
    BMC Infect Dis; 2013 Dec; 13():599. PubMed ID: 24354657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The plasmid-encoded transcription factor ArdK contributes to the repression of the IMP-6 metallo-β-lactamase gene blaIMP-6, leading to a carbapenem-susceptible phenotype in the blaIMP-6-positive Escherichia coli strain A56-1S.
    Segawa T; Sekizuka T; Suzuki S; Shibayama K; Matsui M; Kuroda M
    PLoS One; 2018; 13(12):e0208976. PubMed ID: 30533034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.